Download The Global Market for Adjunctive Therapies in Cancer, 2nd Edition Brochure

Brochure
More information from http://www.researchandmarkets.com/reports/2860758/
The Global Market for Adjunctive Therapies in Cancer, 2nd Edition
Description:
Adjunctive therapies are not only vital to the success of cancer treatments, enhancing compliance and
outcomes, but they are also a dynamic area of research and development in a variety of disciplines from
drug delivery to biologics. It also happens to be the largest portion of the overall cancer therapeutics market.
This report provides the reader with a comprehensive analysis of the worldwide market for therapeutics to
treat and manage symptoms in cancer patients. Market information, including market size and growth, is
provided for 2003 to 2010 on various product subcategories included in the major segments: antinauseants
and antiemetics
pain management
blood modifiers
infection control
other therapies.
In addition, competitive market share and a four-region geographic breakdown are provided for the base
year 2005. The study also covers issues and trends affecting the market, research and development
pipelines, demographics, cancer statistics, the epidemiology of side effects, and more.
Contents:
Chapter one: Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting the Global Market
Leading Competitors
Chapter Two: Introduction
Overview of Cancer
Biology of Cancer
Treatments and Symptoms
Chemotherapy
Radiation Therapy
Adjunctive Therapy Overview: Product Types and Administration
Oral
Rectal
Transdermal and Nasal
Intravenous or Subcutaneous
Demographics, Prevalence, Incidence, Mortality
Chapter three: Issues and Trends
Overview
Geographical Trends
United States
European Union
Japan
Regulatory Authorities
Clinical Trials
New Indications
Lifestyle and Social Issues
Barriers to Adjunctive Therapies
Drug Delivery Advancements
Pain Management Measures
Oxycontin Issues
Cancer-Related Fatigue Issues
Individualized Chemotherapy
Chemotherapy and Memory Loss
chapter Four: Antinauseants and Antiemetics
Overview
Products
Serotonin Receptor Antagonists
Phenothiazines
Metoclopramide and Other Drugs
Drug Delivery Methods for Antinauseants and Antiemetics
Research and Development
Market Overview
Competitive Analysis
chapter Five: Pain Management
Overview
Pain Pathways
Primary Cancer Pain
Breakthrough Cancer Pain
Cancer Pain Delivery Methods
Oral
Oral Transmucosal
Parenteral
Transdermal
Rectal
Intranasal
Description of Products
Primary Cancer Pain Medications
Non-Narcotic Analgesics
Narcotic Analgesics
Breakthrough Cancer Pain Medications
Antidepressants
Anticonvulsants
Corticosteroids
Bisphosphonates and Calcitonins
Radiopharmaceuticals
Other
Research and Development
Market Overview
Competitive Analysis
chapter six: Biological Response Modifiers
Overview
Description of Products
Hematopoietic Growth Factors
Granulocyte Colony-Stimulating Factor (G-CSF)
Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF)
Epoetin Alpha
Darbepoetin Alfa
Epoetin Beta
Human keratinocyte growth factor
Cytomodulatory Agents
Research and Development
Market Overview
Competitive Analysis
chapter seven: Infection Control
Overview
Description of Products
Anti-Bacterials and Antivirals
Antifungals
Research and Development
Market Overview
Competitive Analysis
chapter eight: Other Adjunctive Therapies
Overview
Fatigue
Anorexia/Cachexia/Weight Loss
Diarrhea
Constipation
Alopecia (Hair Loss)
Radiation-Induced Dermatitis
Other
Description of Products
Fatigue
Anorexia/Cachexia/Weight Loss
Diarrhea
Constipation
Hair Loss
Radiation-Induced Dermatitis
Research and Development
Market Overview
Competitive Analysis
Chapter Nine: Market Summary
Overview
Market Size
Competitive Analysis
Market Analysis
chapter Ten: Company Profiles
Introduction
Competitive Summary
Abbott Laboratories
Amgen, Inc.
Bayer Corp.
Cephalon , Inc
Chugai Pharmaceutical Company Ltd.
Eli Lilly & Co.
GlaxoSmithKline plc
Johnson & Johnson
Novartis Pharmaceuticals Corp.
Pfizer, Inc.
Roche Group
Sanofi -Aventis
APPENDIX: Company Directory
List of Exhibits
Chapter one: Executive Summary
Table 1-1: Cancer Incidence and Deaths as a Percentage to Population by Selected Country/Region 2005
Table 1-2: Summary Table: The World Market for Adjunctive Therapies in Cancer Revenues and Growth
Rate 2003-2010
Figure 1-1: Summary Figure: The World Market for Adjunctive Therapies in Cancer 2003-2010
Chapter Two: Introduction
Table 2-1: List of Cancers
Table 2-2: Side Effects Associated with Chemotherapy
Table 2-3: Side Effects Associated with Radiation Therapy
Table 2-4: Population by Country 2003-2010
Figure 2-1: Population by Major Market Country 2005 vs. 2010
Table 2-6: Cancer Incidence and Mortality by Major Market Country 2005
Figure 2-3: Cancer Incidence by Major Market Country 2005
Figure 2-4: Cancer Deaths by Major Market Country 2005
Table 2-8: Cancer Incidence and Deaths as a Percentage to Population by Selected Major Market
Country/Region
chapter Four: Antinauseants and Antiemetics
Figure 4-1: Incidence of Emesis in Cancer Patients
Table 4-1: Chemotherapy Agents and Level of Emetic Potential
Table 4-2: Time Course of Selected Products in Nausea and Vomiting
Table 4-3: Selected Prescription Antinauseants/Antiemetics by Available Delivery Method
Table 4-4: Antinauseants and Antiemetics in Development for Treatment of
Cancer related Nausea and Vomiting
Table 4-5: The Adjunctive Antinauseant and Antiemetic Market 2003-2010
Figure 4-1: The Adjunctive Antinauseant and Antiemetic Market 2003-2010
Table 4-6: The Adjunctive Antinauseant and Antiemetic Market, Estimated
Sales by Geographic Region, 2005
Figure 4-2: The Adjunctive Antinauseant and Antiemetic Market by Geographic Region, 2005
Table 4-7: Leading Suppliers’ Revenues and Share of the Antinauseants and Antiemetics Segment 2005
Figure 4-3: Leading Suppliers’ Shares of the Antinauseants and Antiemetics Segment 2005
chapter Five: Pain Management
Figure 5-1: Incidence of Pain in Cancer Patients
Table 5-1: The World Health Organization Three-Step Analgesic Ladder
Table 5-2: Selected Prescription Non-Narcotic Analgesics by Available Delivery Method
Table 5-3: Selected Over-the-Counter Non-Narcotic Analgesics by Available
Delivery Method
Table 5-4: Selected Prescription Narcotic Analgesics by Available Delivery
Method
Table 5-5: Selected Prescription Antidepressants Used for Cancer Pain by
Available Delivery Method
Table 5-6: Selected Prescription Anticonvulsants Used for Cancer Pain by
Available Delivery Method
Table 5-7: Selected Prescription Corticosteroids Used for Cancer Pain by
Available Delivery Method
Table 5-8: Selected Prescription Bisphosphonates and Calcitonins Used for
Cancer Pain by Available Delivery Method
Table 5-9: Selected Prescription Radiopharmacuticals Used for Cancer Pain by Available Delivery Method
Table 5-10: Pain Management Products in Development for Treatment of Cancer Related Pain
Table 5-3: The Adjunctive Pain Management Market 2003-2010
Figure 5-1: The Adjunctive Pain Management Market 2003-2010
Table 5-4: The Adjunctive Pain Management Market, Estimated Sales by Geographic Region, 2005
Figure 5-2: The Adjunctive Pain Management Market by Geographic
Region, 2005
Table 5-5: Leading Suppliers’ Revenues and Shares of the Cancer Pain
Management Segment 2005
Figure 5-3: Leading Suppliers’ Shares of the Cancer Pain Management
Segment 2005
chapter six: Biological Response Modifiers
Figure 6-1: Frequency of Bone Marrow Suppression in Cancer Patients
Table 6-1: Selected Biological Response Modifiers and Available Delivery
Method
Table 6-2: Biological Response Modifiers in Development for Treatment of
Cancer Related Infection
Table 6-3: The Adjunctive Biological Response Modifier Market 2003-2010
Figure 6-2: The Adjunctive Biological Response Modifier Market 2003-2010
Table 6-4: The Adjunctive Biological Response Modifier Market, Estimated
Sales by Geographic Region, 2005
Figure 6-3: The Adjunctive Biological Response Modifier Market, Market by Geographic Region, 2005
Table 6-5: Leading Suppliers’ Revenues and Shares of the Biological Response Modifiers Segment 2005
Figure 6-4: Leading Suppliers’ Market Share of the Biological Response
Modifiers Segment 2005
chapter seven: Infection Control
Table 7-1: Common Infection Sites and Organisms
Figure 7-1: Frequency of Infection in Cancer Patients
Table 7-2: Selected Prescription Antibacterial and Antiviral Agents and
Available Delivery Method
Table 7-3: Selected Prescription Antifungals and Available Delivery Method
Table 7-4: Anti-Infective Agents and Antifungals in Development for
Treatment of Cancer related Infection
Table 7-3: The Adjunctive Infection Control Market 2003-2010
Figure 7-1: The Adjunctive Infection Control Market 2003-2010
Table 7-4: The Adjunctive Infection Control Market Estimated Sales by
Geographic Region, 2005
Figure 7-2: The Adjunctive Infection Control Market by Geographic
Region, 2005
Table 7-5: Leading Suppliers’ Revenues and Shares of the Infection Control Segment 2005
Figure 7-3: Leading Suppliers’ Market Shares of the Infection Control
Segment 2005
chapter eight: Other Adjunctive Therapies
Figure 8-1: Frequency of Fatigue in Cancer Patients
Figure 8-2: Incidence of Anorexia/ Cachexia/Weight Loss in Cancer
Patients
Figure 8-3: Incidence of Diarrhea in Cancer Patients
Figure 8-4: Incidence of Constipation in Cancer Patients
Table 8-1: Selected Chemotherapy Agents and Level of Hair Loss Potential
Figure 8-5: Frequency of Hair Loss in Cancer Patients
Figure 8-6: Prevalence of Other Conditions in Cancer Patients (Sexual/
Reproductive, Heart, Liver, Lung, Nerve, Kidney/Urinary Damage)
Table 8-2: Selected Prescription and Non-prescription Products to Minimize Symptoms of Fatigue in Cancer
Patients and Their Available
Delivery Method
Table 8-3: Selected Prescription Products for the Treatment of Anorexia/
Cachexia in Cancer Patients and Available Delivery Method
Table 8-4: Selected Prescription and Non-prescription Products for the
Treatment of Diarrhea in Cancer Patients and Available Delivery Method
Table 8-5: Selected Prescription and Non-prescription Products for the
Treatment of Constipation in Cancer Patients and Available
Delivery Method
Table 8-6: Selected Prescription and Non-prescription Products for the
Treatment of Radiation-induced Dermatitis
Table 8-7: Other Adjunctive Therapies in Development for Treatment of
Cancer
Table 8-8: The Adjunctive Therapy Other Products Market 2003-2010
Figure 8-7: The Adjunctive Therapy Other Products Market 2003-2010
Table 8-9: The Adjunctive Therapy Other Products Market, Estimated Sales by Geographic Region, 2005
Figure 8-8: The Adjunctive Therapy Other Products Market by Geographic
Region, 2005
Chapter Nine: Market Summary
Table 9-1: The World Market for Adjunctive Therapies in Cancer 2003-2010
Figure 9-1: The World Market for Adjunctive Therapies in Cancer 2003-2010
Table 9-2: The Global Market for Adjunctive Therapies in Cancer by
Type, 2003-2010
Figure 9-2: The World Market for Adjunctive Therapies in Cancer Revenues by Type 2003-2010
Figure 9-3: The World Market for Adjunctive Therapies in Cancer Estimated Market Share by Product Type
2005
Table 9-5: Leading Suppliers, Products, and Segments of Participation 2005
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2860758/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
The Global Market for Adjunctive Therapies in Cancer, 2nd Edition
Web Address:
http://www.researchandmarkets.com/reports/2860758/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Hard Copy:
USD 3500 + USD 58 Shipping/Handling
Electronic (PDF) Single User:
USD 3500
Electronic (PDF) Enterprisewide:
USD 7000
* Shipping/Handling is only charged once per order.
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World